Zhejiang Hisoar Stock Hits Day Low of CNY 6.86 Amid Price Pressure

Zhejiang Hisoar Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.23% as it reached an intraday low of CNY 6.86. This performance stands in contrast to the China Shanghai Composite, which fell by 1.39% on the same day. Over the past week, Zhejiang Hisoar has seen a more significant downturn, with a decrease of 8.61%, while its monthly performance reflects a decline of 7.75%. Despite a positive annual performance of 36.63%, the company has faced challenges in the longer term, with a three-year decline of 5.74% and a five-year drop of 17.46%. Key financial metrics indicate low profitability, with a Return on Capital Employed (ROCE) of just 2.16%. Additionally, the company reported a net profit loss of CNY 83.69 million, marking a significant decline of 162.86%. Zhejiang Hisoar's market capitalization stands at CNY 11,906 million, categorizing it as a large-cap company within the pharmaceuticals and biotechnology sector. The stock's current trading conditions suggest heightened risk compared to historical valuations.